CTx-1301 Comparative Bioavailability Study

NCT04138498 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: Dexmethylphenidate 5 Mg Oral Capsule, Extended Release
DRUG: Dexmethylphenidate 6.25 mg Tablet
DRUG: Dexmethylphenidate 40 Mg Oral Capsule, Extended Release
DRUG: Dexmethylphenidate 50 mg Tablet

Sponsor

Cingulate Therapeutics